A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristics

Critical Reviews in Oncology/Hematology

Volumn 67, Issue 1, 2008, Pages 80-92

  Durbecq, V ^a   Ameye, L ^a   Veys, I ^a   Paesmans, M ^a   Desmedt, C ^a   Sirtaine, N ^a   Sotiriou, C ^a   Bernard Marty, C ^a   Nogaret, J M ^a   Piccart, M ^a   Larsimont, D ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Ageing; Elderly; HER 2; Luminal; Molecular subtypes

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; AGING; BREAST CANCER; CANCER GRADING; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HORMONE DEPENDENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LUMINAL B TUMOR; MAJOR CLINICAL STUDY; METASTASIS; REVIEW; TUMOR; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 44649165728     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.12.008     Document Type: Review

References (56)

1. Baranovsky A., and Myers M.H. Cancer incidence and survival in patients 65 years of age and older. Cancer 36 (1986) 26-41
2. Franceschi S., and La Vecchia C. Cancer epidemiology in the elderly. Crit Rev Oncol Hematol 39 (2001) 219-226
3. DePinho R.A. The age of cancer. Nature 408 (2000) 248-254
4. Dolle M.E., Snyder W.K., Dunson D.B., et al. Mutational fingerprints of aging. Nucleic Acids Res 30 (2002) 545-549
5. Pike M.C., Krailo M.D., Henderson B.E., et al. Hormonal risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303 (1983) 767-770
6. Eppenberger-Castori S., Moore D.H., Thor A.D., et al. Age-associated biomarker profiles of human breast cancer. Int J Biochem Cell Biol 34 (2002) 1318-1330
7. Clark G.M. The biology of breast cancer in older women. J Gerontol 47 (1992) 19-23
8. Peer P.G., van Dijck J.A., Hendriks J.H., et al. Age dependent growth rate of primary breast cancer. Cancer 71 (1993) 3547-3551
9. Schaefer G., Rosen P.P., Lesser M.L., et al. Breast carcinoma in elderly women: pathology, prognosis and survival. Pathol Annu 19 (1984) 195-219
10. Bonnier P., Romain S., Chapin C., et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62 (1995) 138-144
11. Clark G.M., Wenger C.R., Beardslee S., et al. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer 71 (1993) 2157-2162
12. Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92 (1992) 550-556
13. Anderson W.F., Chu K.C., Chatterjee N., et al. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J Clin Oncol 19 (2001) 18-27
14. Perou C., Jeffrey S., van de Rijn M., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96 (1999) 9212-9217
15. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98 (2001) 10869-10874
16. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100 (2003) 8418-8423
17. Sotiriou C., Neo S.Y., McShane L.M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100 (2003) 10393-10398
18. Sotiriou C., Wirapati P., Loi S., et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98 (2006) 262-272
19. Loi S., Haibe-Kains B., Desmedt C., et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25 (2007) 1239-1246
20. Roylance R., Gorman P., Harris W., et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 59 (1999) 1433-1436
21. Allred D.C., Harvey J.M., Berardo M., et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11 (1998) 155-168
22. Nielsen T.O., Hsu F.D., Jensen K., et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10 (2004) 5367-5374
23. Rosen P.P., Lesser M.L., and Kinne D.W. Breast carcinoma in extremes of age: a comparison of patients younger than 35 and older than 75 years. J Surg Oncol 28 (1985) 90-96
24. Allen K., Cox E., Manton K., et al. Breast cancer in the elderly: current patterns of care. J Am Geriatr Soc 34 (1986) 637-642
25. Molino A., Giovannini M., Auriemma A., et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 59 (2006) 226-233
26. Daidone M.G., Coradini D., Matelli G., et al. Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit Rev Oncol Hematol 45 (2003) 313-325
27. Hebert-Croteau N., Brisson J., Latreille J., et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85 (1999) 1104-1113
28. Martelli G., Moglia D., Boracchi P., et al. Surgical resection plus tamoxifen or treatment of breast cancer in elderly patients: a retrospective study. Eur J Cancer 28 (1993) 2080-2085
29. Nixon A.J., Neuberg D., Hayes D.F., et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12 (1984) 888-894
30. Clark G.M., Osborne C.K., and McGuire W.L. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2 (1984) 1102-1109
31. Quong J., Eppenberger-Castori S., Moore D., et al. Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res Treat 76 (2002) 221-236
32. Nikolic-Vukosavljevic D., Kanjer K., Neskovic-Konstantinovic Z., et al. Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer. Int J Biol Markers 17 (2002) 196-200
33. Keshgegian A.A., and Cnaan A. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome. Arch Pathol Lab Med 120 (1996) 970-973
34. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350 (1997) 1047-1059
35. Burger H.G. The endocrinology of the menopause. J Steroid Biochem Mol Biol 69 (1999) 31-35
36. van Landeghem A.A.J., Poortman J., Nabuurs M., et al. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45 (1985) 2900-2906
37. Vermeulen A., Deslypere J.P., Paridaens R., et al. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22 (1986) 515-525
38. Pasqualini J.R., Chetrite G., Blacker C., et al. Concentrations of estrone, estradiol, and estrone sulphate and evaluation of sulfatase and aromatase activities in pre-and postmenopausal breast cancer. J Clin Endocrinol Metab 81 (1996) 1460-1464
39. Chetrite G.S., Cortes-Prieto J., Philippe J.C., et al. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72 (2000) 23-27
40. Clarke R., Leonessa F., Welch J.N., et al. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53 (2001) 1-47
41. Chetrite G.S., and Pasqualini J.R. The selective estrogen enzyme modulator (SEEM) in breast cancer. J Steroid Mol Biol 76 (2001) 95-104
42. Clarke R.B. Human breast proliferation and its relationship to steroid receptor expression. Climateric 7 (2004) 129-137
43. Santner S.J., Feil P.D., and Santen R.J. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59 (1984) 29-33
44. Nakata T., Takashima S., Shiotsu Y., et al. Role of steroid sulfatase in local formation of estrogen in postmenopausal breast cancer patients. J Steroid Biochem Mol Biol 86 (2003) 455-460
45. Miyoshi Y., Ando A., Hasegawa S., et al. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin Cancer Res 9 (2003) 2288-2293
46. Gennari R., Curigliano G., Rotmensz N., et al. Breast carcinoma in elderly women. Features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 101 (2004) 1303-1310
47. Krtolica A., and Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 34 (2002) 1401-1414
48. Krtolica A., Parrinello S., Lockett S., et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 98 (2001) 12072-12077
49. Parrinello S., Coppe J.P., Krtolica A., et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118 (2005) 485-496
50. Parker J., Gebretsadik T., Sabogal F., et al. Mammography screening among California medicare beneficiaries: 1993-1994. Am J Prev Med 15 (1998) 198-205
51. McCarthy E.P., Burns R.B., Freund K.M., et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 48 (2000) 1226-1233
52. Singh R., Hellman S., and Heimann R. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer 100 (2004) 1807-1813
53. Poltinnikov I.M., Rudoler S.B., Tymofyeyev Y., et al. Impact of HER-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer. Am J Clin Oncol 29 (2006) 71-79
54. Ezzat A., Raja M.A., Zwaan F., et al. The lack of age as a significant prognostic factor in non-metastatic breast cancer. Eur J Surg Oncol 24 (1998) 23-27
55. Fisher C.J., Egan M.K., Smith P., et al. Histopathology of breast cancer in relation to age. Br J Cancer 75 (1997) 593-596
56. Ribeiro-Silva A., Ribeiro do Vale F., and Zucoloto S. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma. Am J Clin Pathol 125 (2006) 512-518